These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 22572153)

  • 1. Screening for cystic fibrosis-related diabetes: a systematic review.
    Waugh N; Royle P; Craigie I; Ho V; Pandit L; Ewings P; Adler A; Helms P; Sheldon C
    Health Technol Assess; 2012; 16(24):iii-iv, 1-179. PubMed ID: 22572153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug treatments for managing cystic fibrosis-related diabetes.
    Onady GM; Stolfi A
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD004730. PubMed ID: 33075159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity and specificity of different methods for cystic fibrosis-related diabetes screening: is the oral glucose tolerance test still the standard?
    Mainguy C; Bellon G; Delaup V; Ginoux T; Kassai-Koupai B; Mazur S; Rabilloud M; Remontet L; Reix P
    J Pediatr Endocrinol Metab; 2017 Jan; 30(1):27-35. PubMed ID: 27977404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis].
    Khammar A; Stremler N; Dubus JC; Gross G; Sarles J; Reynaud R
    Arch Pediatr; 2009 Dec; 16(12):1540-6. PubMed ID: 19854630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical updates in cystic fibrosis-related diabetes.
    Brennan AL; Beynon J
    Semin Respir Crit Care Med; 2015 Apr; 36(2):236-50. PubMed ID: 25826591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF.
    Scully KJ; Brenner L; Martin K; Ruazol M; Sawicki GS; Uluer A; Neuringer I; Yonker LM; Sicilian L; Putman MS
    Front Endocrinol (Lausanne); 2024; 15():1293709. PubMed ID: 38379863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis related diabetes (CFRD)--the end stage of progressive insulin deficiency.
    Hameed S; Jaffé A; Verge CF
    Pediatr Pulmonol; 2011 Aug; 46(8):747-60. PubMed ID: 21626717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystic Fibrosis-Related Diabetes Screening in Adults: A Gap Analysis and Evaluation of Accuracy of Glycated Hemoglobin Levels.
    Gilmour JA; Sykes J; Etchells E; Tullis E
    Can J Diabetes; 2019 Feb; 43(1):13-18. PubMed ID: 30173928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycated hemoglobin cannot yet be proposed as a screening tool for cystic fibrosis related diabetes.
    Boudreau V; Coriati A; Desjardins K; Rabasa-Lhoret R
    J Cyst Fibros; 2016 Mar; 15(2):258-60. PubMed ID: 26905501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous glucose monitoring systems for monitoring cystic fibrosis-related diabetes.
    Toner A; McCloy A; Dyce P; Nazareth D; Frost F
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013755. PubMed ID: 34844283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes and Prediabetes in Children With Cystic Fibrosis: A Systematic Review of the Literature and Recommendations of the Italian Society for Pediatric Endocrinology and Diabetes (ISPED).
    Mozzillo E; Franceschi R; Piona C; Passanisi S; Casertano A; Pjetraj D; Maltoni G; Calcaterra V; Cauvin V; Cherubini V; D'Annunzio G; Franzese A; Frongia AP; Lombardo F; Lo Presti D; Matteoli MC; Piccinno E; Predieri B; Rabbone I; Scaramuzza AE; Toni S; Zucchini S; Maffeis C; Schiaffini R
    Front Endocrinol (Lausanne); 2021; 12():673539. PubMed ID: 34017312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystic fibrosis related diabetes mellitus - diagnostic and management challenges.
    Lek N; Acerini CL
    Curr Diabetes Rev; 2010 Jan; 6(1):9-16. PubMed ID: 20034372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological management of cystic fibrosis related diabetes.
    Moheet A; Moran A
    Expert Rev Clin Pharmacol; 2018 Feb; 11(2):185-191. PubMed ID: 29268054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic fibrosis-related diabetes: an update on pathophysiology, diagnosis, and treatment.
    Alves C; Della-Manna T; Albuquerque CTM
    J Pediatr Endocrinol Metab; 2020 Jul; 33(7):835-843. PubMed ID: 32651985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in cystic fibrosis-related diabetes: Current status and future directions.
    Lurquin F; Buysschaert M; Preumont V
    Diabetes Metab Syndr; 2023 Nov; 17(11):102899. PubMed ID: 37939435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary interventions for managing glucose abnormalities in cystic fibrosis: a systematic review protocol.
    Birch L; Lithander FE; Hewer SL; Harriman K; Hamilton-Shield J; Perry R
    Syst Rev; 2018 Jul; 7(1):98. PubMed ID: 30021636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of cystic fibrosis related diabetes: a selective approach in performing the oral glucose tolerance test based on a combination of clinical and biochemical criteria.
    Yung B; Kemp M; Hooper J; Hodson ME
    Thorax; 1999 Jan; 54(1):40-3. PubMed ID: 10343630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HbA1c as a screening tool for cystic fibrosis related diabetes.
    Burgess JC; Bridges N; Banya W; Gyi KM; Hodson ME; Bilton D; Simmonds NJ
    J Cyst Fibros; 2016 Mar; 15(2):251-7. PubMed ID: 25869326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal screening of patients with cystic fibrosis-related diabetes in Wales -- a real eye opener.
    Roberts R; Speight L; Lee J; George L; Ketchell RI; Lau D; Duckers J
    J Cyst Fibros; 2015 Mar; 14(2):282-4. PubMed ID: 25224328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CF-related diabetes: Containing the metabolic miscreant of cystic fibrosis.
    Moheet A; Moran A
    Pediatr Pulmonol; 2017 Nov; 52(S48):S37-S43. PubMed ID: 28714601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.